Pfizer Inc (NYSE:PFE)
| 49.94 Delayed Data As of Aug 10 |  +0.16 / +0.32%Today’s Change | 40.94 Today|||52-Week Range 61.71 | -15.43% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Damelio Frank A Executive Vice President |  Buy | 2/23/2022 | 153,789 | $27.34 | $4.2M | +6.57% |
Damelio Frank A Executive Vice President |  Sale | 2/23/2022 | 76,120 | $51.28 | $3.9M | +6.57% |
Damelio Frank A Executive Vice President | Buy | 2/26/2022 | 127,160 | $25.60 | $3.3M | +6.41% |
Lankler Douglas M Executive Vice President | Buy | 2/23/2022 | 115,342 | $27.34 | $3.2M | +6.57% |
Damelio Frank A Executive Vice President | Sale | 2/26/2022 | 59,370 | $50.64 | $3.0M | +6.41% |
Lankler Douglas M Executive Vice President | Sale | 2/23/2022 | 57,090 | $51.28 | $2.9M | +6.57% |
Young John D Group President | Sale | 11/11/2021 | 47,782 | $50.01 | $2.4M | -0.46% |
Mackenzie Alexander Roderick Executive Vice President | Sale | 12/02/2021 | 41,360 | $54.26 | $2.2M | -5.83% |
Bourla Albert Chairman & Chief Executive Officer | Buy | 12/17/2021 | 80,080 | $27.34 | $2.2M | -16.02% |
Dolsten Mikael President-Research & Development | Buy | 12/17/2021 | 71,187 | $30.17 | $2.1M | -16.02% |
Page of 14